 |
 |
Madenco Biosciences Creates New Line of Cosmeceuticals to Complement Bellus Skin™ Serum for Anti-Aging
EDMONTON, ALBERTA – Madenco Biosciences Inc., a subsidiary of Quest PharmaTech Inc., focused on bringing clinically validated products to the consumer and dermatology market by utilizing proprietary transdermal delivery technologies, announced today that they have created the SP-DERM line of cosmeceuticals specifically targeting applications that are demanded by dermatologists and medi-spas.